16 clinical trials found.
-
Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD)
Inflammatory Bowel Diseases (IBD) are treated with many different medications, none of which are 100% effective. One of the challenges of treating IBD is to ...Phase N/A
TRIAL ROLE: Principal Investigator
-
A Phase 3 Multicenter Open-Label Extension Trial of Oral RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
The purpose of this study is to see whether ozanimod (RPC1063), (also referred to as the ‘study drug’), is safe and how well it works ...Phase
TRIAL ROLE: Principal Investigator
-
A phase III randomized double blind parallel group placebo controlled international multicentre study to assess efficacy and safety of Cx601 adult allogeneic expanded adipose-derived stem cells (eASC) for the treatment of complex perianal fistula(
The purpose of this study is to confirm (1) how well the investigational drug, Cx601, works at a single dose of 120 million cells compared ...Phase
TRIAL ROLE: Principal Investigator
-
Corrona Inflammatory Bowel Disease (IBD) Registry
The purpose of this registry study is to learn more about Inflammatory Bowel Disease (IBD), how doctors treat IBD, how well medications and other treatments ...Phase N/A TRIAL ROLE: Principal Investigator
-
TARGET-IBD: A 5-year longitudinal observational study of patients undergoing therapy for inflammatory bowel disease (IBD)
This study is looking to enroll patients with inflammatory bowel disease (IBD), which may include Crohn's disease (CD), ulcerative colitis (UC) and Indeterminate Colitis ...Phase N/A TRIAL ROLE: Principal Investigator
-
A Multicenter Randomized Double-Blind Parallel-Group Study to Assess the Efficacy and Safety of Oral Etrasimod as Induction and Maintenance Therapy for Moderately to Severely Active Crohn s Disease
The purpose of this study is to assess an investigational drug called etrasimod (also referred to as the “study drug”) in the treatment of Crohn ...Phase
TRIAL ROLE: Principal Investigator
-
Induction Optimization with Stelara for Crohn s Disease
The purpose of this study is to compare the effectiveness of a second weight based dose of Stelara given intravenously to the standard dose administered ...Phase
TRIAL ROLE: Principal Investigator
-
Proactive infliximab optimization using a pharmacokinetic dashboard versus standard of care in patients with Crohn s disease: The OPTIMIZE Trial
The purpose of this study is to find out if using a computer program (called iDose) to guide infliximab dosing is more effective and safer ...Phase N/A TRIAL ROLE: Principal Investigator
-
Serologic Testing and Genomic Analysis of Autoimmune ImmuneMediated and Rheumatic Patients with COVID-19 (SAGA)
The purpose of this study is to obtain blood samples and nasal swab samples of patients with autoimmune and inflammatory diseases to see if certain ...Phase N/A TRIAL ROLE: Co-Investigator
-
A Randomized Double-Blind Placebo-Controlled. Multi-center Proof-of-Mechanism Phase 2a Study to Evaluate the Safety Tolerability and efficacy of TAK-018 (EB8018) for the Prevention of Post-Operative Crohn s Disease Recurrence.
The main purpose of this study is to evaluate how safe and tolerable a drug called TAK-018 (or sibofimloc,the “Takeda Study Drug”) is in ...Phase
TRIAL ROLE: Sub Investigator
